• Home
  • Technology
  • Science
  • Publications
  • Investors
  • Contact Us
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Technology
  • Science
  • Publications
  • Investors
  • Contact Us

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

The MeCo Score is a prognostic and predictive biomarker that stratifies early-stage breast cancer patients for risk of metastasis caused by mechanical conditioning, and it provides the rationale for targeted prevention in high-risk patients using low-toxicity antifibrotic drugs as "mechanical deconditioning therapy."

Find out more


The MeCo Score (TM) is an investigational assay that is not approved or demonstrated to be safe or effective for any use.

Copyright © 2022 MeCo Diagnostics HOLDINGS, INC. - All Rights Reserved.